Civetta Therapeutics, LLC is a pioneering biotechnology company based in Cambridge, MA, dedicated to unlocking the therapeutic potential of propeller proteins. With a focus on protein-protein interactions, Civetta utilizes a rigorous and comprehensive evaluation of this recurrent protein structural motif to target critical interactions and address previously inaccessible biology with a high degree of selectivity.
Through their innovative approach, Civetta Therapeutics aims to control the function of diverse biological complexes associated with disease progression, offering new perspectives in the field of therapeutics. With a team of experienced scientists and a culture that values creativity and pioneering spirit, Civetta is at the forefront of groundbreaking research and development in the biotechnology industry.
Generated from the website